Copyright
©The Author(s) 2017.
Figure 4 Different wound beds in the same burn.
A: Burn before Nexobrid® treatment; B: After Nexobrid® treatment with three different wound bed. Type IIa, Type IIb and Type III, with a fatty wound bed (full thickness burn)
- Citation: Palao R, Aguilera-Sáez J, Serracanta J, Collado JM, Dos Santos BP, Barret JP. Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve. World J Dermatol 2017; 6(2): 32-41
- URL: https://www.wjgnet.com/2218-6190/full/v6/i2/32.htm
- DOI: https://dx.doi.org/10.5314/wjd.v6.i2.32